Blog Archives

An annual Sjogren’s treatment update for 2020

2020 has been a long year for everyone, and Sjogren’s patients aren’t excluded. I’ve encountered some technical difficulties with this site which delayed this post, but I believe the significant issues have been fixed. The most unfortunate news is that

Posted in Clinical Trials, Treatment Tagged with: ,

Sjogren’s Syndrome clinical trial updates, including Orencia (abatacept)

There was a much longer gap than I expected since my last post, so I’d like to start by looking at some updates in the clinical trial space for Sjogren’s Syndrome. The first trial I would like to look at

Posted in Clinical Trials, Research, Treatment Tagged with: , ,

Thanksgiving update with BCG vaccine study results

It’s been 6 months since my last post, largely due to a busy schedule and technical issues. I changed computers, and had a little trouble transferring my site management setup. I’ve also had to stop taking Plaquenil/hydroxychloroquine this summer, and

Posted in Clinical Trials, Research, Treatment Tagged with: ,

ImmuPharma’s Lupuzor fails to meet the primary endpoint in its phase 3 trial

I woke to extremely disappointing news this morning. In my Hope for 2016 post, I mentioned peptide based drugs as my #2 hope, with Lupuzor being the key candidate. Over the past several years, I have watched the Lupuzor trials

Posted in Clinical Trials, Treatment Tagged with: ,

Another dry eye treatment, Elate by Cambium, cleared for phase 1/2 trials

It has been nearly 15 years since Restasis was approved to treat dry eyes. SS patients had to make due with Restasis until last year when Xiidra was approved. The floodgates seemed to have opened, as a variety of dry eye

Posted in Clinical Trials, Research, Treatment Tagged with: , ,

RSLV-132 – Another Sjogren’s Syndrome treatment enters clinical trials

I try to track new entries on clinicaltrials.gov, and a few weeks ago I noticed a new entry in the SS space; a phase 2 trial for a new drug labeled RSLV-132 in the United Kingdom. The company sponsoring the trial, Resolve

Posted in Clinical Trials, Research, Treatment Tagged with:

Lamelleye and Lacripep enter clinical trials, adding more eye drop options for Sjogren’s Syndrome patients

Sjogren’s Syndrome patients are experiencing a growing number of options for treating dry eyes. Restasis (Ciclosporin) was the first, and a treatment with which I’ve found some success. Xiidra (Lifitegrast) was approved just last year, and while it is an eye

Posted in Clinical Trials, Treatment Tagged with:

New Sjogren’s Syndrome Clinical Trial: Filgotinib, GS-9876 and Tirabrutinib

It’s Sjogren’s Syndrome Awareness month, and I’m very behind on posting. To get started, I thought I would note a new clinical trial that appeared at the end of March: Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults

Posted in Clinical Trials, Treatment Tagged with: ,

New Sjogren’s Syndrome Clinical Trial List and Overview

As my readers may have noticed, I’m very interested in clinical trials relating to Sjogren’s Syndrome. Unfortunately, the main source of clinical trial information, clinicaltrials.gov, can be difficult to navigate. I have yet to find a site that gives an

Posted in Clinical Trials, Website

Sjogren’s Syndrome Clinical Trial Updates – Abatacept and BMS-986142

It’s been a busy month, but I wanted to squeeze at least one post in before November. There are a couple of interesting clinical trial developments I thought I would elaborate upon. Abatacept/Orencia I posted a few months ago about a

Posted in Clinical Trials, Treatment Tagged with: ,
WordPress Appliance - Powered by TurnKey Linux